Neuropsychiatric systemic lupus erythematosus: Where are we now?;L'interessamento neuro-psichiatrico nel lupus eritematoso sistemico: A che punto siamo?

Reumatismo

Volumn 57, Issue 4, 2005, Pages 215-225

  Govoni, Marcello ^a   Rizzo, N ^a   Castellino, G ^a   Padovan, M ^a   Trotta, F ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PHOSPHOLIPID ANTIBODY;

CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; CYTOKINE RELEASE; CYTOTOXICITY; DISEASE ACTIVITY; DISEASE REGISTRY; HEADACHE; HISTOPATHOLOGY; HUMAN; MOOD DISORDER; NEUROIMAGING; NEUROPSYCHIATRY; PATHOGENESIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

COGNITION DISORDERS; HEADACHE; HUMANS; INCIDENCE; ITALY; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MOOD DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 33646804937     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Brey RL, Petri M. Neuropsychiatric systemic lupus erythematosus: miles to go before we sleep. Neurology 2003; 61: 9-10.
2. Bryun GAW. Controversies in lupus: nervous system. Ann Rheum Dis 1995; 54: 159-67.
3. Omdal R. Some controversies of neuropsychiatric systemic lupus erythematosus. Scand J Rheumatol 2002; 31: 192-7.
4. Diamond B, Volpe B. On the track of neuropsychiatric lupus. Arthritis Rheum 2003; 48: 2710-2.
5. Ruggieri AP. Neuropsychiatric lupus: nomenclature, classification, criteria, and other confusional states. Arthritis Rheum 2001; 45: 406-9.
6. Singer J, Denburg JA. Diagnostic criteria for neuropsychiatric systemic lupus erythematosus: the results of a consensus meeting. The Ad Hoc Neuropsychiatric Lupus Workshop Group. J Rheumatol 1990; 17: 1397-402.
7. Rood MJ, Breedveld FC, Huizinga TW. The accuracy of diagnosing neuropsychiatric systemic lupus erythematosus in a series of 49 hospitalized patients. Clin Exp Rheumatol 1999; 17: 55-61.
8. ACR ad hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology. Arthritis Rheum 1999; 42: 599-608.
9. Kassan SS, Lockshin MD. Central nervous system lupus erythematosus. The need for classification. Arthritis Rheum 1979; 22: 1382-5.
10. Ainiala H, Hietaharju A, Loukkola J, Peltola J, Korpela M, Metsanoja R, et al. Validity of the new American College of Rheumatology criteria for neuropsichiatric lupus syndromes: a population based evaluation. Arthritis Rheum (Arthritis Care Res) 2001; 45: 419-23.
11. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology 2002; 41: 619-30.
12. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology 2002; 41: 605-18.
13. Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004; 31: 2156-62.
14. McCune WJ, Golbus J. Neuropsychiatric lupus. Rheum Dis Clin North Am 1988; 14: 149-67
15. Feinglass EJ, Arnett FC, Dorsch CA, Zizic TM, Stevens MB. Neuropsychiatric manifestations of systemivc lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976; 55: 323-39.
16. Dubois EL, Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus. computer analysis of 520 cases. JAMA 1964; 190: 104-11.
17. Toubi E, Khamashta MA, Panarra A, Hughes GR. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995; 99: 397-401.
18. West SG, Emlen W, Wener MH, Kotzin BL. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med 1995; 99: 153-63.
19. Trotta F, Dovigo L, Govoni M, et al. Neuropsychiatric involvement in Systemic lupus erythematosus. A clinical and instrumental study in 116 North Italian Patients. Eur J Intern Med 1997; 8: 95-103.
20. Mok CC, Lau CS, Wong RW. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol. 2001; 28: 766-71.
21. Costallat LTL, Bertolo MB, Appenzeller S, Campinas AMS. The applicability of the American College of Rheumatology Nomenclature and case definitions for neuropsychiatric lupus syndrome. Analysis of 527 patients. Arthritis Rheum 2001; 44 (suppl), S198 (Abs. n. 873).
22. Kasitanon N, Louthrenoo W, Piyasirisilp S, Sukitawu W, Wichainun R. Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus. A 15 year experience. Ann Rheum Dis 2002; 61(suppl. 1):96.
23. Cervera R. Lessons from the "Euro-Lupus Cohort". Ann Med Interne 2002; 153: 530-6.
24. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001; 57: 496-500.
25. Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 985-92.
26. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002; 58: 1214-20.
27. Afeltra A, Garzia P, Mitterhofer AP, Vadacca M, Galluzzo S, Del Porto F, et al. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 2003; 61: 108-10.
28. Leritz E, Brandt J, Minor M, Reis-Jensen F, Petri M. Subcortical cognitive impairment in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 2000; 6: 821-5.
29. Carbotte RM, Denburg SD, Denburg JA. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986; 174: 357-64.
30. Hanly JG, Fisk JD, Sherwood G, et al. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992; 19: 562-7.
31. Carlomagno S, Migliaresi S, Ambrosone L, Sannino M, Sanges G, Di Iorio G. Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 2000; 247: 273-9.
32. Denburg SD, Carbotte RM, Denburg JA. Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol 1987; 9: 323-39.
33. Kozora E, West SG, Kotzin BL, Julian L, Porter S, Bigler E. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1998; 41: 41-7.
34. Waterloo K, Omdal R, Sjoholm H, Koldingsnes W, Jacobsen EA, Sundsfjord JA, et al. Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J Neurol 2001; 248: 595-602.
35. Sabbadini MG, Manfredi AA, Bozzolo E, Ferrario L, Rugarli C, Scorza R, et al. Central nervous system involvement in systemic lupus erythematosus patient without overt neuropsychiatric manifestations. Lupus 1999; 8: 11-9.
36. Tomietto P, Annese V, D'Agostini S, Gremese E, Di Poi E, Ferraccioli G. Neuropsychological tests, MRI and SPECT in the evaluation of CNS involvement in SLE. Reumatismo 2003; 55: 171-80.
37. Kozora E, Ellison MC, West S. Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus. Arthritis Rheum 2004; 51: 810-8.
38. De Marcaida JA, Reik L Jr. Disorders that mimic central nervous system infections. Neurol Clin 1999; 17: 901-41.
39. Toubi E, Khamasta MA, Panarra A, Hughes GR. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995; 99: 397-401.
40. West SG, Emlen W, Wener MH, Kotzin BL. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med 1995; 99: 155-63.
41. Sastre-Garriga J, Montalban X. APS and the brain. Lupus 2003; 12: 877-82.
42. Sanna G, Bertolaccini ML, Cuadrado MJ, Khamashta MA, Hughes GR: Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology 2003; 42: 200-13.
43. Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca RR, et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004; 291: 576-84.
44. Katzav A, Chapman J, Shoenfeld Y. CNS dysfunction in the antiphospholipid sindrome. Lupus 2003; 12: 903-7.
45. Bluestein HG, Williams GW, Steinberg AD. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 1981; 70: 240-6.
46. Williams GW, Bluestein HG, Steinberg AD. Brain-reactive lymphocytotoxic antibody in the cerebrospinal fluid of patients with systemic lupus erythematosus: correlation with central nervous system involvement. Clin Immunol Immunopathol 1981; 18: 126-32.
47. De Giorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibosies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001; 7: 1189-93.
48. Omdal R, Brokstad K, Waterloo K Koldingsnes W, Jonsson R, Mellgren SI. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol 2005; 12: 392-8.
49. Williams RC, Sugiura K, Tan EM. Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2004; 50: 1239-47.
50. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, et al. Association between lupus psychosis and anti-ribosomal P-protein antibodies. N Engl J Med 1987; 317: 265-71.
51. Gerli R, Caponi L, Tincani A, Scorza R, Sabbadini MG, Danieli MG, et al. Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of italian patients. Rheumatology 2002; 41: 1357-66.
52. Conti F, Alessandri C, Bompane D, Bombardieri M, Spinelli FR, Rusconi AC, et al. Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res Ther 2004; 6: 366-72.
53. Senecal JL, Raymond Y. The pathogenesis of neuropsychiatric manifestations in systemic lupus erythematosus: a disease in search of autoantibodies, or autoantibodies in search of a disease? J Rheumatol 2004; 31: 2093-8.
54. Colamussi P, Govoni M. The role of nuclear medicine in the evaluation of neuropsychiatric systemic lupus erythematosus: comment on the article by Sibbitt et al. Arthritis Rheum 2000; 43: 1903-4.
55. Castellino G, Govoni M, Padovan M, Colamussi P, Borrelli M, Trotta F. Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi- imaging approach and follow-up. Ann Rheum Dis 2005; 64: 1022-7.
56. Govoni M, Castellino G, Padovan M, Borrelli M, Trotta F. Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus. Lupus 2004; 13: 149-58.
57. Sibbitt WL Jr, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1999; 42: 2026-38.
58. Borrelli M, Tamarozzi R, Colamussi P, Govoni M, Trotta F, Lappi S. Evaluation with MR, perfusion MR and cerebral flowSPECT in NPSLE patients. Radiol Med (Torino) 2003; 105: 482-9.
59. Padovan M, Locaputo A, Rizzo N, Govoni M, Trotta F. The evaluation of neuropsychiatric lupus erythematosus by functional neuroimaging. Preliminary results. Reumatismo 2004; 56: 24-30.
60. Trysberg E, Nylen K, Rosengren LE, Tarkowski A. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum 2003; 48: 2881-7.
61. Sanna G, Bertolaccini ML, Mathieu A. Central nervous system lupus: a clinical approach to therapy. Lupus 2003; 12: 935-42.